Received May 18, 2026
Reports are unverified and do not show that a vaccine caused an event. Full disclaimer
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTPPVHBHPB | DTAP+IPV+HIB+HEPB (VAXELIS) | MSP VACCINE COMPANY | UNK | U8309AA | — |
| RV5 | ROTAVIRUS (ROTATEQ) | MERCK & CO. INC. | UNK | 2142135 | OT |
No additional AE; one patient was administered vaccines after temperature excursion; This spontaneous report was received from a registered nurse and referred to a patient of unknown age and gender. The patient's medical history, current condition and concomitant medications were not reported. On 04-Nov-2025, patient received improper storage of rotavirus vaccine, live, oral, pentavalent (ROTATEQ) vial, 2 (unit not reported) orally (lot number: 2142135 with expiration date: 28-May-2026, dose text: 2ml/once); and was vaccinated with improper storage of diphtheria and tetanus toxoids (+) acellular pertussis (+) inactivated poliovirus (+) hib conjugate (mpc) and rhbv vaccine (VAXELIS) injection 0.50 mL (lot number: U8309AA with expiration date: 30-Sep-2027, dose text: 0.5ml/once, route unknown), both for prophylaxis (Product storage issue). No additional adverse event reported. Administered doses of rotavirus vaccine, live, oral, pentavalent (ROTATEQ) and diphtheria and tetanus toxoids (+) acellular pertussis (+) inactivated poliovirus (+) hib conjugate (mpc) and rhbv vaccine (VAXELIS) experienced the temperature excursion below 10.2 degree Celsius for 0 hours 50 minutes 0 seconds. No previous temperature excursions reported.